About
Steve La Neve was appointed President and Chief Executive Officer of Accuray and a member of the Board of Directors effective October 20, 2025, succeeding Suzanne Winter. He brings more than 40 years of global medical technology and biotechnology leadership spanning capital equipment and implantable devices. He most recently served as President of the Trauma and Joint Reconstruction business and of Globus Medical Japan K.K. at Globus Medical (2019-2024), and previously as CEO of Bone Biologics Corporation, CEO of ETEX Corporation, Global President of Becton Dickinson Pre-Analytical Systems, and Global President of Medtronic Spine and Biologics. He holds a B.S. in Health Planning and Administration from Pennsylvania State University and an MBA from West Chester University.
Roles
Accuray Inc.
President and Chief Executive Officer · Current role
October 2025–present
Accuray Incorporated
President and Chief Executive Officer
October 2025 - present
Globus Medical
President, Trauma and Joint Reconstruction; President, Globus Medical Japan K.K.
2019 - 2024
Bone Biologics Corporation
Chief Executive Officer and Director
2015 - 2019
Life Science Enterprises, Inc.
Chief Executive Officer
2014 - 2015
ETEX Corporation
Chief Executive Officer
2014
Becton Dickinson
Global President, Pre-Analytical Systems
—
Medtronic
Global President, Spine and Biologics; President, Medtronic Japan
—
External Roles
Insight Medbotics
Board member
present
Fixed Compensation
FY 2026
Annual base salary
$750,000
Performance Compensation
Data from FY 2026
Cash incentive
Target annual incentive
$750,000